Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
L'obsit touche dsormais plus d'un milliard de personnes dans le monde, selon une tude publie en mars dans la revue mdicale britannique The Lancet
Our formulations are science-forward and designed with one goal in mind: making sure the nutrients actually reach your cells
The molecule is classified as a triple receptor agonist because it interacts with three endocrine receptors involved in metabolic regulation: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
With altRx, you get more than a medicationyou get a guided, supportive pathway to long lasting results
Pre-Clinical Development Vaccine construct design Upstream process development Formulation Analytical development Potency assay development Product characterization studies Animal immunogenicity Technology transfer to a GMP Contract Manufacturing Organization (CMO) Engineering batches by CMO GMP cell banking Toxicology studies Stability data Clinical Development Dossier submission for Phase 1 IND application Regulatory approval for Phase 1 Phase 1 clinical trial Phase 1, into the clinic The Phase 1 study is usually the first assessment of a vaccine in humans
US$ 21.20
US$ 21.84
US$ 20.48
